These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7718898)

  • 1. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II.
    Vieira LM; Kaplan JC; Kahn A; Leroux A
    Blood; 1995 Apr; 85(8):2254-62. PubMed ID: 7718898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) gene.
    Kugler W; Pekrun A; Laspe P; Erdlenbruch B; Lakomek M
    Hum Mutat; 2001 Apr; 17(4):348. PubMed ID: 11295830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b(5) reductase gene leading to methemoglobinemia type I.
    Dekker J; Eppink MH; van Zwieten R; de Rijk T; Remacha AF; Law LK; Li AM; Cheung KL; van Berkel WJ; Roos D
    Blood; 2001 Feb; 97(4):1106-14. PubMed ID: 11159544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia.
    Manabe J; Arya R; Sumimoto H; Yubisui T; Bellingham AJ; Layton DM; Fukumaki Y
    Blood; 1996 Oct; 88(8):3208-15. PubMed ID: 8874222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three novel mutations in CYB5R3 gene causing NADH-cytochrome b5 reductase enzyme deficiency leads to recessive congenital methaemoglobinemia.
    Deorukhkar A; Kulkarni A; Kedar P
    Mol Biol Rep; 2022 Mar; 49(3):2141-2147. PubMed ID: 35064402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutation (R192C) in CYB5R3 gene causing NADH-cytochrome b5 reductase deficiency in eight Indian patients associated with autosomal recessive congenital methemoglobinemia type-I.
    Kedar PS; Gupta V; Warang P; Chiddarwar A; Madkaikar M
    Hematology; 2018 Sep; 23(8):567-573. PubMed ID: 29482478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency.
    Katsube T; Sakamoto N; Kobayashi Y; Seki R; Hirano M; Tanishima K; Tomoda A; Takazakura E; Yubisui T; Takeshita M
    Am J Hum Genet; 1991 Apr; 48(4):799-808. PubMed ID: 1707593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase.
    Percy MJ; Gillespie MJ; Savage G; Hughes AE; McMullin MF; Lappin TR
    Blood; 2002 Nov; 100(10):3447-9. PubMed ID: 12393396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis.
    Aalfs CM; Salieb-Beugelaar GB; Wanders RJ; Mannens MM; Wijburg FA
    Hum Mutat; 2000; 16(1):18-22. PubMed ID: 10874300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum and molecular basis of recessive congenital methemoglobinemia in India.
    Warang PP; Kedar PS; Shanmukaiah C; Ghosh K; Colah RB
    Clin Genet; 2015; 87(1):62-7. PubMed ID: 24266649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant.
    Percy MJ; Crowley LJ; Roper D; Vulliamy TJ; Layton DM; Barber MJ
    Blood Cells Mol Dis; 2006; 36(1):81-90. PubMed ID: 16310381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia.
    Wang Y; Wu YS; Zheng PZ; Yang WX; Fang GA; Tang YC; Xie F; Lan FH; Zhu ZY
    Blood; 2000 May; 95(10):3250-5. PubMed ID: 10807796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity of two missense mutations in the NADH-cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemia.
    Grabowska D; Plochocka D; Jablonska-Skwiecinska E; Chelstowska A; Lewandowska I; Staniszewska K; Majewska Z; Witos I; Burzynska B
    Eur J Haematol; 2003 Jun; 70(6):404-9. PubMed ID: 12756024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel point mutation (Leu72Pro) in the NADH-cytochrome b5 reductase gene of a patient with hereditary methaemoglobinaemia type I.
    Wu YS; Huang CH; Wan Y; Huang QJ; Zhu ZY
    Br J Haematol; 1998 Jul; 102(2):575-7. PubMed ID: 9695975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme.
    Shirabe K; Fujimoto Y; Yubisui T; Takeshita M
    J Biol Chem; 1994 Feb; 269(8):5952-7. PubMed ID: 8119939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase Gene.
    Forestier A; Pissard S; Cretet J; Mambie A; Pascal L; Cliquennois M; Cambier N; Rose C
    Hemoglobin; 2015; 39(6):438-41. PubMed ID: 26291966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type).
    Shirabe K; Yubisui T; Borgese N; Tang CY; Hultquist DE; Takeshita M
    J Biol Chem; 1992 Oct; 267(28):20416-21. PubMed ID: 1400360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and biological forms of cytochrome b5 reductase deficiency].
    Kaplan JC; Leroux A; Beauvais P
    C R Seances Soc Biol Fil; 1979; 173(2):368-79. PubMed ID: 159760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia.
    Shirabe K; Landi MT; Takeshita M; Uziel G; Fedrizzi E; Borgese N
    Am J Hum Genet; 1995 Aug; 57(2):302-10. PubMed ID: 7668255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel point mutation in NADH-cytochrome b5 reductase gene].
    Wang Y; Wu Y; Yang W
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):521-3. PubMed ID: 11721397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.